ScholarIQanswers from OpenAlex
Kliniken Essen-Mitte
InstitutionResearch output, impact & collaborations
Kliniken Essen-Mitte is a institution indexed in ScholarIQ from OpenAlex.
What is known about Kliniken Essen-Mitte?
ScholarIQrecord summary
Kliniken Essen-Mitte is a research organisation in Essen, DE. OpenAlex records 4,836 works and 375,708 citations for it. 915 researchers list it as their most recent affiliation.
How many works does Kliniken Essen-Mitte have?
ScholarIQindexed works
Kliniken Essen-Mitte has 4,836 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kliniken Essen-Mitte have?
ScholarIQcitation count
Kliniken Essen-Mitte has 375,708 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Kliniken Essen-Mitte?
ScholarIQresearcher count
Kliniken Essen-Mitte has 915 researchers in the ScholarIQ index.
What is the average h-index at Kliniken Essen-Mitte?
ScholarIQavg h-index
Kliniken Essen-Mitte has an average h-index of 71 in OpenAlex.
What is the ROR of Kliniken Essen-Mitte?
ScholarIQror
The ROR for Kliniken Essen-Mitte is on the source record.
What is the OpenAlex record for Kliniken Essen-Mitte?
ScholarIQopenalex
The OpenAlex for Kliniken Essen-Mitte is on the source record.
Who are the most-cited researchers behind Kliniken Essen-Mitte?
ScholarIQtop researchers by citations
What are the most-cited papers on Kliniken Essen-Mitte?
ScholarIQmost cited works
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid, Javier Cortés, Lajos Pusztai, Heather L. McArthur, Sherko Kümmel, Jonas Bergh, Carsten Denkert, Yeon Hee Park, Rina Hui, Nadia Harbeck, Masato Takahashi, Theodoros Foukakis, Peter A. Fasching, Fátima Cardoso, Michael Untch, Liyi Jia, Vassiliki Karantza, Jing Zhao, Gursel Aktan, Rebecca Dent, Joyce O’Shaughnessy
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder, Andreas du Bois, Jalid Sehouli, Rainer Kimmig, Anne Stähle, Fiona Collinson, Sharadah Essapen, Charlie Gourley, Alain Lortholary, Frédèric Selle, Mansoor R. Mirza, Arto Leminen, Marie Plante, Dan Stark, Wendi Qian, Mahesh Parmar, Amit M. Oza
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani, Bianca Lederer, Barbara Ingold Heppner, Karsten E. Weber, Jan Budczies, Jens Huober, Frederick Klauschen, Jenny Furlanetto, Wolfgang Schmitt, Jens‐Uwe Blohmer, Thomas Karn, Berit M. Pfitzner, Sherko Kümmel, Knut Engels, Andreas Schneeweiß, Arndt Hartmann, Aurelia Noske, Peter A. Fasching, Christian Jackisch, Marion van Mackelenbergh, Hans‐Peter Sinn, Christian Schem, Claus Hanusch, Michael Untch, Sibylle Loibl
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Nicoletta Colombo, Cristiana Sessa, Andreas du Bois, Jonathan A. Ledermann, W. Glenn McCluggage, Iain A. McNeish, Philippe Morice, Sandro Pignata, Isabelle Ray‐Coquard, Ignace Vergote, Thaïs Baert, I. Belaroussi, A. Dashora, Siel Olbrecht, François Planchamp, Denis Querleu, Thaïs Baert, Susana Banerjee, I. Belaroussi, Paweł Blecharz, Ilan Bruchim, David Cibula, Nicoletta Colombo, Nicole Concin, Ben Davidson, A. Dashora, Mojgan Devouassoux‐Shisheboran, Andreas du Bois, Annamaria Ferrero, Rosalind Glasspool, Antonio González-Martı́n, Viola Heinzelmann‐Schwarz, Florence Joly, J.W. Kim, Frédéric Kridelka, Jonathan A. Ledermann, Domenica Lorusso, Sven� Mahner, W. Glenn McCluggage, Iain A. McNeish, Mikio Mikami, Mansoor Raza Mirza, Philippe Morice, Shibani Nicum, Siel Olbrecht, Dearbhaile M. O’Donnell, Patricia Pautier, François Planchamp, Sandro Pignata, Denis Querleu, Isabelle Ray‐Coquard, Alexandros Rodolakis, Jalid Sehouli, Fatih Selçukbırıcık, Cristiana Sessa, Nilanchali Singh, David S.P. Tan, D. Timmerman, Germana Tognon, Jacobus van der Velden, Ignace Vergote, Petronella O. Witteveen, Alain G. Zeimet
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gϋnter von Minckwitz, Andreas Schneeweiß, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens‐Uwe Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M. Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Dan Costa, Hans Tesch, Claus Hanusch, J. Hilfrich, F Khandan, Peter A. Fasching, Bruno V. Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch
How much of the research on Kliniken Essen-Mitte is open access?
ScholarIQopen access share
58%OPEN ACCESS